Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹418.50
14.95 (3.70%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹67.83K Cr
MID CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
177.4
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹331+26.4%
52W High₹440.4-5.0%
Current Price
₹418.50
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹334.80
Upper Circuit₹502.20
Reference Price
₹418.50
Investment Checklist
Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹448.65
Rising Wedge on 1D — target ₹338.0
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Composite score 44.13 (BUY) with 48.8% confidence
10/20 Bearish Cross detected 3 day(s) ago
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
49%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
414.61
EMA50
407.93
EMA200
388.25
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows4
Lower Highs5
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹424.95
₹432.15
₹440.40
Support (Below)
₹412.50
₹404.79
₹386.96
₹371.52
₹359.05
Volume Analysis
TrendINCREASING
Change+37.20%
Unusual VolumeNo
Recent MA Crossovers
10/20 Bearish Cross
3 days ago
SELL
Stop Loss Levels
Fixed Risk
1% Risk₹414.31
3% Risk₹405.94
5% Risk₹397.57
7% Risk (Custom)
₹389.20Technical Levels
1x ATR (Volatility)₹406.60
2x ATR (Swing)₹394.70
3x ATR (Trend)₹382.80
Immediate Support₹412.50
Moving Averages
EMA 9 (Short-term)₹413.04
EMA 20 (Medium-term)₹414.61
EMA 50 (Trend)₹407.93
EMA 200 (Long-term)₹388.25
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹4,358.1 Cr | ₹3,910.1 Cr | ₹4,262.5 Cr | ₹4,173 Cr |
| Net Profit | ₹344.5 Cr | ₹31.4 Cr | ₹84.5 Cr | ₹143.8 Cr |
| EPS | — | ₹0.26 | ₹0.66 | ₹1.08 |
| Operating Profit | ₹1,125.8 Cr | ₹828.6 Cr | ₹916.5 Cr | ₹657.4 Cr |
ROE
4.68%
ROCE
6.93%
Debt/Equity
0.85
Current Ratio
1.14
OPM
15.75%
NPM
3.45%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Biocon Limited | ₹418.50 | +3.70% | 177.4 | ₹67.83K Cr mid Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 03 Jul 2026 | Dividend - Re 0.50 Per Share | DIVIDEND |
| 04 Jul 2025 | Dividend - Rs 0.50 Per Share | DIVIDEND |
| 05 Jul 2024 | Dividend - Re 0.50 Per Share | DIVIDEND |
| 07 Jul 2023 | Dividend - Rs 1.50 Per Share | DIVIDEND |
| 30 Jun 2022 | Dividend - Rs 0.50 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for BIOCON
View All
negative
CNBC TV18 - Markets 1d ago
Biocon shares in focus as Viatris-owned Mylan plans stake sale via block deal: Sources
Viatris-owned Mylan is looking to sell part of its 5.64% stake in Biocon through a block deal in the next seven to eight days, according to sources. The size, pricing and buyers are yet to be determined.
BIOCONFOCUSConsumer DurablesHealthcare
positive
LiveMint - Companies 5d ago
True North cashes out $2 billion for investors as PE firms step up exits
This comes on the back of exits for True North from portfolio firms like FedFina, Niva Bupa, Biocon Biologics, Infinity Fincorp Solutions, Zydus Wellness and Home First Finance.
BIOCONFEDFINAHOMEFIRSTLTFNIVABUPAREPCOHOMERHFLUYFINCORPWEALTHZYDUSWELLFast Moving Consumer GoodsFinancial Services
neutral
NDTV Profit 5d ago
Five Stocks To Buy: Biocon, IndusInd Bank, Angel One And More | July 6, 2026
Five stocks to buy on July 6.
ANGELONEAONEGOLDAONELIQUIDAONENIFTYAONESILVERAONETMMQ50AONETOTALBANKINDIABIOCONINDUSINDBKFinancial ServicesHealthcare